Vega Ramiro; Juan Antonio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vega Ramiro; Juan Antonio.The latest application filed is for "oga inhibitor compounds".

Company Profile

0.17.26

Vega Ramiro; Juan Antonio - Olias del Rey ES
Vega Ramiro; Juan Antonio - Toledo ES
Vega Ramiro; Juan Antonio - Olias del Rey Toledo

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oga Inhibitor Compounds App 20210300900 - Bartolome-Nebreda; Jose Manuel ; et al.	2021-09-30
Oga Inhibitor Compounds App 20210300943 - Bartolome-Nebreda; Jose Manuel ; et al.	2021-09-30
Oga Inhibitor Compounds App 20210277015 - Bartolome-Nebreda; Jose Manuel ; et al.	2021-09-09
Oga Inhibitor Compounds App 20210122763 - Bartolome-Nebreda; Jose Manuel ; et al.	2021-04-29
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders Grant 10,071,095 - Cid-Nunez , et al. September 11, 2	2018-09-11
5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE) Grant 9,840,507 - Trabanco-Suarez , et al. December 12, 2	2017-12-12
1,2,4-Triazolo [4,3-A] Pyridine Derivatives And Their Use For The Treatment Of Prevention Of Neurological And Psychiatric Disorders App 20170333426 - CID-NUNEZ; Jose Maria ; et al.	2017-11-23
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders Grant 9,737,533 - Cid-Nunez , et al. August 22, 2	2017-08-22
6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (BACE) Grant 9,346,811 - Trabanco-Suarez , et al. May 24, 2	2016-05-24
1,2,4-Triazolo [4,3-A] Pyridine Derivatives and Their Use For The Treatment of Prevention of Neurological and Psychiatric Disorders App 20160067245 - CID-NUNEZ; JOSE MARIA ; et al.	2016-03-10
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors Grant 9,271,967 - Cid-N nez , et al. March 1, 2	2016-03-01
1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders Grant 9,226,930 - Cid-Nunez , et al. January 5, 2	2016-01-05
1,2,4-Triazolo [4,3-A] Pyridine Derivatives and Their Use For The Treatment of Prevention of Neurological and Psychiatric Disorders App 20150141403 - CID-NUNEZ; Jose Maria ; et al.	2015-05-21
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors Grant 9,012,448 - Cid-N nez , et al. April 21, 2	2015-04-21
1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors Grant 8,993,591 - Cid-N nez , et al. March 31, 2	2015-03-31
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders Grant 8,937,060 - Cid-Nunez , et al. January 20, 2	2015-01-20
Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors Grant 8,785,486 - Trabanco-Suarez , et al. July 22, 2	2014-07-22
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS App 20140155393 - Cid-N nez; Jose Maria ; et al.	2014-06-05
6,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-4-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) App 20140005200 - Trabanco-Suarez; Andres Avelino ; et al.	2014-01-02
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS App 20130338185 - Cid-N nez; Jose Maria ; et al.	2013-12-19
5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) App 20130274266 - Trabanco-Suarez; Andres Avelino ; et al.	2013-10-17
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS App 20130252952 - Cid-N nez; Jose Maria ; et al.	2013-09-26
5-amino-3,6-dihydro-1h-pyrazin-2-one Derivatives Useful As Inhibitors Of Beta-secretase (bace) App 20130079349 - Trabanco-Suarez; Andres Avelino ; et al.	2013-03-28
1,2,3-triazolo [4,3-a] Pyridine Derivatives And Thier Use For The Treatment Of Prevention Of Neurological And Psychiatric Disorders App 20120184525 - Cid-Nunez; Jose Maria ; et al.	2012-07-19
Imidazo[1,2-a]pyridine Derivatives And Their Use As Positive Allosteric Modulators Of Mglur2 Receptors App 20110009441 - Trabanco-Suarez; Andres Avelino ; et al.	2011-01-13
Substituted Pyrazinone Derivatives For Use As A Medicine App 20100105694 - Andres-Gil; Jose Ignacio ; et al.	2010-04-29
Substituted Triazoline, Tetrazolone And Imidazolone Derivatives For Use As A Medicine App 20100029620 - Andres-Gil; Jose Ignacio ; et al.	2010-02-04
Substituted Pyrazinone Derivatives For Use As A Medicine App 20090281099 - Andres-Gil; Jose Ignacio ; et al.	2009-11-12
Substituted Pyrazinone Derivatives For Use As A Medicine App 20090111801 - Andres-Gil; Jose Ignacio ; et al.	2009-04-30
Substituted Pyrazinone Derivatives as Alpha2C-Adrenoreceptor Antagonists App 20080269251 - Andre-Gil; Jose Ignacio ; et al.	2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.